Skip to main content
Fig. 2 | Orphanet Journal of Rare Diseases

Fig. 2

From: Increased phototoxic burn tolerance time and quality of life in patients with erythropoietic protoporphyria treated with afamelanotide – a three years observational study

Fig. 2

Correlation of PBTT and days since the last dose of afamelanotide. The first afamelanotide dose a patient ever received was defined as being equal to 1000 days of treatment interruption. PBTT inversely and significantly correlated to the time span to the last dose of afamelanotide (Kendall’s tau = − 0.382, n = 82; p < 0.0001)

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172